• Changes In The Capacity Of Neurological And Psychiatric Inpatient Care In Hungary Between 1990 And 2014

    Nov 1, 2016, 00:00

  • Retrospective Study of Frequency and Cost of Multiple Myeloma (MM) Complications and Treatment Related Adverse Events (AES)

    Nov 1, 2016, 00:00

  • Cost Of Dengue Illness And Cost-Effectiveness Of The Cdy-Tdv Dengue Vaccine In Ecuador

    Nov 1, 2016, 00:00

  • One-Year Patient-Reported Persistence To Antiresorptive Treatment In A Fracture Liaison Servi The Lucky Bone™ Program

    Nov 1, 2016, 00:00

  • The Association Between Initiation of Guideline Recommended First-Line Systemic Therapy and Healthcare Costs and Utilization in a Metastatic Non-Small Cell Lung Cancer (MNSCLC ) Population

    Nov 1, 2016, 00:00

  • A Systematic Literature Review to Identify Clinical Drivers in Cost-Effectiveness Analyses in T2DM Patients Uncontrolled on Current Therapies

    Nov 1, 2016, 00:00

  • Clinical Evaluation of Punarnavadi Mandoora And Tryushanadi Loha in Patients of Obesity

    Nov 1, 2016, 00:00

  • All-Cause Mortality and Cardiovascular Events After Acute Myocardial Infarction and 12-Months Dual Platelet-Aggregation Inhibition in Clinical Practice. Findings from the Piper Study

    Nov 1, 2016, 00:00

  • Health Technology Assessments of Lama/Laba Combination Products

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Gazyvaro in Association to Chlorambucil for Patients with Chronic Lymphocytic Leukemia When Full-Dose Fludarabine is Unsuitable in France

    Nov 1, 2016, 00:00

  • Traditional and Complementary Medicine Use Among Women to Conceive and During Pregnancy- A Literature Review

    Nov 1, 2016, 00:00

  • Development and Content Validity of the Advanced Systemic Mastocytosis Symptom Assessment Form (ADVSM-SAF)

    Nov 1, 2016, 00:00

  • Application of Risk Adjusted Cost-Effectiveness Analyses for Stroke Treatment

    Nov 1, 2016, 00:00

  • Positive Impact of Indacaterol Launch on Guidelines Compliance And Consequences on COPD Daily Treatment Cost In France

    Nov 1, 2016, 00:00

  • A New Coverage with Evidence Development Dedicated to Innovative Medical Biology and Pathological Anatomy and Cytology Procedures in Fran Overview of the Situation after one Year of Implementation and Focus on Innovative Genetics Procedures ...

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Transfemoral Aortic Valve Implantation Compared with Surgical Aortic Valve and Medical Management in Patients with Severe Symptomatic Aortic Stenosis in Australia

    Nov 1, 2016, 00:00

  • Analysis of Orphan Drugs Reimbursement in Major European HTA Agencies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Ombitasvir/Paritaprevir/Ritonavir With Or Without Dasabuvir For The Treatment Of Chronic Hepatitis C Patients Infected With Genotype 1 Or 4 In France

    Nov 1, 2016, 00:00

  • Review of Health Technology Assessment (HTA) Requirements for Rare Diseases Across European Countries

    Nov 1, 2016, 00:00

  • A Comparison of Long-Term Anticholinergic Burden Derived from Different Risk Scales with Adverse Clinical Outcomes in the Elderly

    Nov 1, 2016, 00:00

  • Sick Leave and Disability Pension in Patients with Chronic Hepatitis C Compared with Matched General Population Comparators- A Nationwide Population-Based Register Study

    Nov 1, 2016, 00:00

  • Systematic Review, Meta-Analysis, and Cost-Effectiveness Model of Invasive Versus Non-Invasive Strategy for Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) in Patients with Prior Coronary Artery Bypass Graft (CABG)

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Injecting A "Dexamethasone Ropivacaine" Mixture Subcutaneously In The Management of Traumatic Bone Surgeries of The Forefoot

    Nov 1, 2016, 00:00

  • what Do we Pay for Compounded Drugs?

    Nov 1, 2016, 00:00

  • Too Old for Treatment- Ageism in Chronic Lymphocytic Leukemia (CLL). A Narrative review of the Literature

    Nov 1, 2016, 00:00

  • Hyperbolic Discounting of Effects in Economic Evaluations

    Nov 1, 2016, 00:00

  • Review of Methods for Combining Individual and Aggregate Data in a Meta-Analysis

    Nov 1, 2016, 00:00

  • Economic Evaluation of Tiotropium/Olodaterol Administrated Through The Respimat Inhaler As Maintenance Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) In Poland

    Nov 1, 2016, 00:00

  • Potential Efficacy of Lomitapide, A MTP (Microsomal Triglyceride Transfer Protein) Inhibitor, on Survival in Homozygous Familial Hypercholesterolaemia (HOFH)- Results of an Event Modelling Analysis

    Nov 1, 2016, 00:00

  • Cost Comparison in the Management of the Renal Cell Carcinoma with in Spain- Pazopanib vs. Sunitinib

    Nov 1, 2016, 00:00

  • Beyond Risk-Based Vaccination Policies - A Life-Course Approach to Vaccination

    Nov 1, 2016, 00:00

  • Defining Episodes of Care for Chronic Diseases- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Effect of Spironolactone on The Risk of New Onset of Diabetes Among Patients with Heart Failure- A Population-Based Study

    Nov 1, 2016, 00:00

  • “Best Supportive Care” or “Therapy According to Physician's Choice” as Appropriate Comparator for German HTA Dossiers – An Underestimated Chance or Risk for the Benefit Assessment?

    Nov 1, 2016, 00:00

  • Indirect Costs Associated with Ulcerative Colitis In Poland

    Nov 1, 2016, 00:00

  • General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In France

    Nov 1, 2016, 00:00

  • Methodology of Research to Determine Cost and Utility of Pilot One-Stop Fertility Clinic Versus Traditional NHS Fertility Investigation Pathway

    Nov 1, 2016, 00:00

  • Impact of Whole Exome Sequencing (WES) on Costs and Medical Decision-Making

    Nov 1, 2016, 00:00

  • Quantifying the Economic Burden of Chronic Spontaneous Urticaria in Portugal – What is the Impact on the Portuguese NHS and in the Society

    Nov 1, 2016, 00:00

  • Economic and Humanistic Benefits of Maintaining Cognitive Impairment Patients in the Early Stage

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Dexamethasone Intravitreal Implant for Treatment of Diabetic Macular Oedema in Spain

    Nov 1, 2016, 00:00

  • Policies for Use of Real-World Data in Health Technology Assessment- A Comparative Study of 6 HTA Agencies

    Nov 1, 2016, 00:00

  • Cost‐Utility Analysis Of Ulipristal Acetate (5 Mg) For Long-Term Treatment Of Moderate To Severe Symptoms Of Uterine Fibroids In Portugal

    Nov 1, 2016, 00:00

  • How Are Fast-Track Programmes Like Rapid Recovery Delivering Value Across Hospitals, Cultures And Healthcare Systems In Orthopedics Within A Cost-Constrained Environment?

    Nov 1, 2016, 00:00

  • Indirect Cost Of Hiv/Aids- Results Of A Survey From A Turkish Research Center

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis Of Tedizolid For The Treatment Of Acute Bacterial Skin And Skin Sub-Structure Infections (Absssi) In Greece

    Nov 1, 2016, 00:00

  • Population Preferences for Rare Diseases in Spain

    Nov 1, 2016, 00:00

  • How To Select The Best Comparator? An International Economic Evaluation Guidelines Comparison

    Nov 1, 2016, 00:00

  • Longitudinal Trend of Human Immunodeficiency Virus (HIV) Prevalence Rates in the United States

    Nov 1, 2016, 00:00

  • Changes of The Reimbursement Recommendations Focused on Oncology Drugs Before and after The Implementation of The 2013 Benefit Enhancement Policy in Korea

    Nov 1, 2016, 00:00

  • Real-World Impact Of Gender, Age And Socio-Economic Status On Type-2 Diabetes Mellitus (T2dm) Patients’ Disease Engagement And Adherence With Treatment Regimens

    Nov 1, 2016, 00:00

  • Imatinib Discontinuation and Tki Switching Patterns in the Retrospective and Prospective Cohorts in Simplicity, A Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (PTS) in Routine Clinical Practice

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Early Tips with Expanded Polytetrafluoroethylene (EPTFE) Covered Stent-Grafts Compared to Endoscopic Procedures to Manage Acute Variceal Bleeding – A Spanish Scenario

    Nov 1, 2016, 00:00

  • Adjustment Of OS In Crystal For Post-Study Anti-Cancer Therapies

    Nov 1, 2016, 00:00

  • Assessment of Patterns of Initiation of Oral Anticoagulant Therapy in Hypertensive Patients with Atrial Fibrillation

    Nov 1, 2016, 00:00

  • The Effect of Therapeutic Drug Monitoring in Patients Complian An Improvement in Drug Efficacy and Corresponding Reduction in Toxicity Using Aminoglycosides

    Nov 1, 2016, 00:00

  • Nice’s Criteria for End-Of-Life Therapies- Is there a Fourth Hurdle to Overcome?

    Nov 1, 2016, 00:00

  • The Impact of Economic Crisis on Drug Consumption and Pharmaceutical Expenditure in Greece

    Nov 1, 2016, 00:00

  • Cost Per Responder of Apremilast Versus Infliximab Biosimilar, Etanercept, Adalimumab, Ustekinumab and Secukinumab in Patients with Moderate to Severe Psoriasis in Spain

    Nov 1, 2016, 00:00

  • Treatment Satisfaction Of Osteoporosis Medication In Postmenopausal Women Of Korea; Results From The Study Of Osteoporosis Medication Adherence And Satisfaction In Postmenopausal Women

    Nov 1, 2016, 00:00

  • Advanced Renal Cell Carcinoma in Previously Treated Patients- Measuring Healthcare Use, Productivity Loss and Costs

    Nov 1, 2016, 00:00

  • Open Versus Endovascular Repair in Patients with Abdominal Aortic Aneurysm in Spain ─ A Cost Comparisson

    Nov 1, 2016, 00:00

  • Neuropathic Pain in Chronic Low Back Pain- A Patient-Centered Approach to Measuring Outcomes

    Nov 1, 2016, 00:00

  • The Determinants Of Innovative Drugs Prices- The Case Of Oncology Drugs, Comparative Analysis

    Nov 1, 2016, 00:00

  • Subclinical Hypothyroidism In Pediatric Population Treated With L-Thyroxine- A Retrospective Observational Analysis on 2001–2014 Administrative Data

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis To Estimate The Cost Savings from Alectinib on Patients With Anaplastic Lymphoma Kinase (ALK) Positive Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) Previously Treated with Crizotinib

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis From The Cost-Effectiveness Perspective- Is Mcda A Coherent Way To Allocate Healthcare Resources?

    Nov 1, 2016, 00:00

  • The Effectiveness Analysis of Selected Radiosurgery Devices on Treatment of Cancer Tumors and Arteriovenous Malformations- A Systematic Review

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Teriflunomide Used For Multiple Sclerosis Patients In Russia

    Nov 1, 2016, 00:00

  • Sacubitril/Valsartan Estimated Cost Savings Based on Paradigm-HF Results

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Secukinumab Compared To Current Biologics Sequences For The Treatment of Moderate To Severe Plaque Psoriasis In France

    Nov 1, 2016, 00:00

  • Diagnostic Accuracy of Assessment Methods for Diagnosing Diabetic Peripheral Neuropathy (DPN)- A Systematic Review and Meta-Analysis- An Evidence Based Approach

    Nov 1, 2016, 00:00

  • Unspecified Intestinal Malabsorption Associated with Angiotensin Receptor Blocker Therapy- Results from a Nationwide, Population-Based Study in Italy and Germany

    Nov 1, 2016, 00:00

  • Validity and Reliability of Three New Instruments for Parents and Children Assessing Nutrition and Physical Activity Behaviors, Environment and Knowledge and Health in Childhood and Adolescence in Greece During the Economic Recession- Data ...

    Nov 1, 2016, 00:00

  • What are the key concerns of health care providers in china? Qualitative investigation of a double-blind telephone survey

    Nov 1, 2016, 00:00

  • Using Clinical Trial and Real World Data to Bridge Efficacy to Effectiveness of Fingolimod in Multiple Sclerosis Patients

    Nov 1, 2016, 00:00

  • Estimated Range of Cost of Treatment of Adult Schizophrenia Patients at a Tertiary Hospital as of October 2015

    Nov 1, 2016, 00:00

  • War Rages Between Infliximab Biosimilars and Their Originator

    Nov 1, 2016, 00:00

  • First Results From A Retrospective Study on the Epidemiology of the Hungarian Hiv Infected Population

    Nov 1, 2016, 00:00

  • Complementary and Alternative Medicine use and Its Association with Quality of Life Among Cancer Patients Receiving Chemotherapy in Ethiopia- A Cross Sectional Study

    Nov 1, 2016, 00:00

  • Community Residents' Knowledge and Perceptions of Antibiotic Resistance in Penang, Malaysia- Findings and Implications

    Nov 1, 2016, 00:00

  • Payer Requirements in the Treatment of Chronic Heart Failure

    Nov 1, 2016, 00:00

  • Establishing an International Reference Pricing Database- an Innovative Tool to Support Drug Pricing Reform in China

    Nov 1, 2016, 00:00

  • Dose Extension and Costs of Lanreotide Autogel 120 Mg Used in Routine Neuroendocrine Tumors Care In Poland – 2- Years Data From Lanro-Net Study

    Nov 1, 2016, 00:00

  • The Economic Burden of Non-Tuberculous Mycobacterial Pulmonary Disease In Canada, France, United Kingdom And Germany

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apremilast In Moderate-To-Severe Psoriasis In Canada

    Nov 1, 2016, 00:00

  • Non-Adherent Behaviour and Glycaemic Control in Patients with Type 2 Diabetes Treated with Insulin

    Nov 1, 2016, 00:00

  • Quality of Life of Stroke Survivors and Their Informal Caregivers- A Prospective Study

    Nov 1, 2016, 00:00

  • What do HTAS Look Like Around the World? A Comparison of South Korean and British HTA Agencies

    Nov 1, 2016, 00:00

  • Phase III Trial of Recombinant Human Parathyroid Hormone in Hypoparathyroidism- A Post-HOC Analysis of Change in Health-State Utility Among Responders

    Nov 1, 2016, 00:00

  • Differential Factors Predicting Major Adverse Cardiovascular Events In Atherosclerotic Patients with and without Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Actuarial Approaches To Modelling and Mitigating Financial Uncertainty in Recommending New Drugs and Health Technologies

    Nov 1, 2016, 00:00

  • Retrospective Survey For Hepatitis B Virus Reactivation During Immunosuppressive Therapies For Rheumatoid With Administrative Data

    Nov 1, 2016, 00:00

  • A Retrospective Study on Association Between Change In Bmi And Incidence Of Hypertension Using A Health Care Database In Japan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Roflumilast As Add-On To Triple Inhaled Therapy Vs Triple Inhaled Therapy In Patients with Severe And Very Severe COPD Associated with Chronic Bronchitis In Sweden

    Nov 1, 2016, 00:00

  • Health-Economic Analysis of The Use of Sensor-Augmented Pump with Predictive Suspend Function (SAP) Therapy in Sweden Compared to Insulin Pump Therapy Alone (CSII), in Type 1 Diabetic Patients

    Nov 1, 2016, 00:00

  • A General Model for The Estimation of Societal Costs of Lost Production and Informal Care In Italy

    Nov 1, 2016, 00:00

  • Mapping of The Biosimilar Drug Policy in 10 Central Eastern European Countries

    Nov 1, 2016, 00:00

  • Current Situation and Prospect of Orphan Drugs in China

    Nov 1, 2016, 00:00

  • Knowledge And Participation Rate on Cervical Cancer Screening Among Romany Minority Population

    Nov 1, 2016, 00:00

  • Economic Analysis of Endovascular Interventions for The Treatment of Femoropopliteal Peripheral Artery Disease in Austria

    Nov 1, 2016, 00:00

  • Cost-Utility analysis of Insulin Degludec vs. Insulin Glargine U100 Treatment in Patients with Diabetes Mellitus type 1 and 2 in Serbia

    Nov 1, 2016, 00:00

  • A Calculating Analysis Model on Disability Adjusted of Life Years Among Patients Suffering from Alzheimer's- Based on The Improvement of Multi-State Markov Model

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Dapagliflozin Versus Glimepiride as Monotherapy in Patients with Type 2 Diabetes Mellitus in China

    Nov 1, 2016, 00:00

  • Reducing Medical Claims Cost to Ghana’s National Health Insurance Scheme- Paper-Based Versus Electronic-Based Claims Review

    Nov 1, 2016, 00:00

  • Intravenous Fluids for Children- Cost and Threshold Analysis to Inform the National Institute for Health and Care Excellence (NICE) Clinical Guideline Recommendation

    Nov 1, 2016, 00:00

  • Psychometric Validation of the Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT®) Questionnaire

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Rivaroxaban For Treatment of Deep Vein Thrombosis And Pulmonary Embolism In Greece

    Nov 1, 2016, 00:00

  • Effects of Opioid use with and without Over-The-Counter Analgesics on Economic Outcomes Among Adults with Pain in the United States

    Nov 1, 2016, 00:00

  • Economic Analyses of Diagnostic Tests for HCC Surveillan A Systematic Review

    Nov 1, 2016, 00:00

  • Chronic Patients Attitudes, Beliefs, and Experiences Regarding Polypharmacy and Willingness to Deprescribein Quetta

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Laparoscopic and Open Surgery for Rectal Cancer

    Nov 1, 2016, 00:00

  • Trends of Including Pharmacoeconomics Course in the Undergraduate Pharmacy Curriculum

    Nov 1, 2016, 00:00

  • General Practitioners Awareness On Medicines Cost And Financing In Bosnia And Herzegovina

    Nov 1, 2016, 00:00

  • Accounting for the Imperfect External Validity of Discrete Choice Experiments When Predicting Demand

    Nov 1, 2016, 00:00

  • Assessment of Knowledge of Urinary Tract Infection (UTI) Amongst School-Going Adolescent Girls

    Nov 1, 2016, 00:00

  • Differences in Cost-Effectiveness Estimates for Chronic Hepatitis C Treatment Among Cohort Markov Model, Markov Microsimulation and Discrete Event Simulation

    Nov 1, 2016, 00:00

  • Relevance And Economic Consequences Of Medicine Waste In Vienna- Analysis Of A Household Garbage Sample

    Nov 1, 2016, 00:00

  • Utilization Of Physiotherapy Visits Completed In Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00

  • The Evaluation of Relationship between Regular Inspection and Committing Major Malpractice in Pakdasht Pharmacies

    Nov 1, 2016, 00:00

  • Investigating the Implementation of Adverse Events in Economic Models- A Systematic Literature Review in Multiple Sclerosis and Human Immunodeficiency Virus

    Nov 1, 2016, 00:00

  • Polypharmacy and Medication Adherence in Elderly Patients with Diabetes in Pafos General Hospital, Cyprus

    Nov 1, 2016, 00:00

  • Economic Modeling of Risk-Adapted Screen-and-Treat Strategies in Women at High-Risk for Breast or Ovarian Cancer

    Nov 1, 2016, 00:00

  • Similarities and Differences of Risk Sharing Arrangements in Australia, United Kingdom, Italy, and Korea

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Crizotinib Among ALK+ NSCLC Patients Across The United States, Western Europe, and Japan

    Nov 1, 2016, 00:00

  • Cost-Outcome Analysis of Different Intravenous Iron Sucrose Preparations in Hemodialysis Patients

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Heart Failure with Preserved Ejection Fraction (HF-PEF) in Turkey- The Results of A Delphi Panel

    Nov 1, 2016, 00:00

  • Cost-Sharing In Healthcare- An Approach For Pharmaceutical Care In Greece

    Nov 1, 2016, 00:00

  • Systematic Review And Meta-Analysis of Accuracy of Diagnostic Tests For Screen Detection of Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The Incorporation of A Computerized Temperature Management System In The Treatment of Therapeutic Hypothermia In Greece

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1b Hcv In Greece

    Nov 1, 2016, 00:00

  • A Proposed Holistic Conceptual Framework for Barriers to Medication Adherence in Diabetes

    Nov 1, 2016, 00:00

  • Systematic Review and Meta-Analysis of Risperidone for the Treatment of Schizophrenia

    Nov 1, 2016, 00:00

  • Generating Consistent and Reliable Evidence on Survival Estimates for Health Technology Assessment in Oncology and Haematology

    Nov 1, 2016, 00:00

  • Feasibility of Electronic Medical Records in Australia, China, and Japan to Support Novelty (A Novel Observational Longitudinal Study of Patients with Asthma and/or COPD)

    Nov 1, 2016, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs Adalimumab Based on A Matching-Adjusted Indirect Comparison For The Treatment of Ankylosing Spondylitis From A German Payer Perspective

    Nov 1, 2016, 00:00

  • Cost-Utility Evaluation of Insulin Glargine 300 (GLA-300) Versus Insulin Glargine 100 (GLA-100) in Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Ibrutinib For Waldenström Macroglobulinemia In Italy

    Nov 1, 2016, 00:00

  • Estimating the Value of A New Antibiotic- A Novel Approach Using Esbl As A Case Study

    Nov 1, 2016, 00:00

  • A Value for Money Threshold for New Technologies for Very Rare Diseases- Does the Nice Highly Specialised Committee Employ One?

    Nov 1, 2016, 00:00

  • Big Data In Healthcare - Opportunities And Challenges

    Nov 1, 2016, 00:00

  • Evaluation of the Effect of Pharmaceutical Care Interventions on the Mean Daily Dose of Oral Antidiabetes Drugs in a Nigerian Tertiary Hospital

    Nov 1, 2016, 00:00

  • Assessment Of Regional Legislation Related To The Use Of Similar Biological Medicinal Products- The Italian Case Study

    Nov 1, 2016, 00:00

  • Use of Nimotuzumab in The Treatment of Locally Advanced Esophageal Cancer in Real World

    Nov 1, 2016, 00:00

  • Analysis on the Utilization Status of Essential Medicines in Beijing's Community Health Institutions

    Nov 1, 2016, 00:00

  • Making Pragmatic Trials Work

    Nov 1, 2016, 00:00

  • Somatic Symptoms in Patients with Undiagnosed Depression- Prevalence and Health Care Utilization In Japan

    Nov 1, 2016, 00:00

  • What is Government's Responsibility for China's Universal Health Security? An Outlook for a National Health Security System

    Nov 1, 2016, 00:00

  • Potential Factors Predicting The Response in The Treatment of Attention-Deficit/Hyperactivity Disorder Children with Atomoxetine in Asia Pacific Region

    Nov 1, 2016, 00:00

  • Dispensing Patterns and Cost of Insulins in Poland Between 2012 and 2015

    Nov 1, 2016, 00:00

  • The Impact of Country-Specific Utility Tariffs on the Outcome of Cost-Utility Analyses; A Case Study

    Nov 1, 2016, 00:00

  • Alemtuzumab Budget Impact For Multiple Sclerosis Treatment In Spain

    Nov 1, 2016, 00:00

  • Adverse Drug Reactions of Radiographic Contrast Media Used in Computed Tomography and Magnetic Resonance Imaging in India

    Nov 1, 2016, 00:00

  • Direct Costs, Work Productivity Loss, And Effectiveness of Treatment Of Rheumatoid Arthritis (RA) Patients Through A Treat-To-Target (T2T) Approach- A Real-World Administrative Database Analysis

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life for People with Chronic Lower Back Pain- Results from a Large, Prospective, Random-Select, Open-Labelled and Blinded End-Point Study, Analysed by Response to Treatment

    Nov 1, 2016, 00:00

  • Budget Impact Model Of Indacaterol/Glycopyrronium In The Treatment Of Copd In Italy Based On Flame Study

    Nov 1, 2016, 00:00

  • The Quev Score- A Quantitative Evaluation of the Quality of Clinical Evidence in HTA

    Nov 1, 2016, 00:00

  • Two New Cancer-Specific Multi-Attribute Utility Instruments- EORTC QLU-C10D and FACT-8D

    Nov 1, 2016, 00:00

  • Vaginal Birth After Caesarean Versus Elective Repeat Caesarean Delivery In Four European Countries- A Cost-Utility Analysis

    Nov 1, 2016, 00:00

  • Cost Analysis of Different Sequential Treatment Regimens for Metastatic Renal Cell Carcinoma in China

    Nov 1, 2016, 00:00

  • The Societal and Humanistic Burden of Small Cell Lung Cancer (SCLC)- A Systematic Review of Societal Impact and Health-Related Quality Of Life (HRQOL) Literature

    Nov 1, 2016, 00:00

  • A Systematic Review on Methodological Heterogeneity in Estimating Productivity Loss Associated with Colorectal Cancer

    Nov 1, 2016, 00:00

  • Government Sponsored Health Insurance Schemes for Reimbursement of Cancer Treatment in India

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life In Patients with Systemic Lupus Erythematosus (SLE)- A Spanish Study Based on Patient Reports

    Nov 1, 2016, 00:00

  • The Quality of Pharmacoeconomic Publications in Breast Cancer Pharmacotherapies in China

    Nov 1, 2016, 00:00

  • Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving while Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in Belgium- A Cost-Utility Study

    Nov 1, 2016, 00:00

  • Stable Multiple Sclerosis Patients on an Interferon Therapy Have Better Outcomes When Staying on Therapy than Patients who Switch to Another Interferon

    Nov 1, 2016, 00:00

  • Mcda Application In Central And Eastern Europe- Selection Of The Most Important Criteria Based On Examples

    Nov 1, 2016, 00:00

  • Regulatory Agencies Perspective on Progression-Free-Survival (PFS)

    Nov 1, 2016, 00:00

  • The Economic Burden Of Chronic Obstructive Pulmonary Disease In China- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • The Pricing and Reimbursement of Specialty Drugs in Key Asian Markets

    Nov 1, 2016, 00:00

  • Sampling of Commonly used Population Characteristics- Is A Normal Approximation Valid?

    Nov 1, 2016, 00:00

  • Management of Metastatic Colorectal Cancer Patients- A Methodological Approach to Identify Treatment Lines

    Nov 1, 2016, 00:00

  • A Study of the Successful Adaptation of the Quality of Life Questionnaire - Bronchiectasis From Paper To Electronic Format

    Nov 1, 2016, 00:00

  • Investigating The Cost-Effectiveness of Genetic Counselling for Couples At Known Risk of Having Children with Tay-Sachs Disease- A Two-Generation Model

    Nov 1, 2016, 00:00

  • Food for Thought (But Not Too Much) for Health Economic Analyes of Nutritional Interventions in Obesity

    Nov 1, 2016, 00:00

  • Impact of Poverty on Health Care Utilization in the Elderly

    Nov 1, 2016, 00:00

  • Cost Assessment for Healthy Diet in the State of Penang, Malaysia

    Nov 1, 2016, 00:00

  • Examining The Relationship Between Suicidal Ideation, Depression and Selected Chronic Diseases Using The Nhanes Dataset

    Nov 1, 2016, 00:00

  • Implementation of Conditional Reimbursement Schemes in HTA Practi Experiences from the Netherlands

    Nov 1, 2016, 00:00

  • Extrapolation with Patient Level Time-To-Event Data in Various Disease Areas- A Review of Current Recommendations and Gaps

    Nov 1, 2016, 00:00

  • Results of HTA in Brazil- The Performance of Conitec in its First Five Years

    Nov 1, 2016, 00:00

  • Utilisation Of Survival Outcomes Data To Forecast Economic Impact Of Pricing And Market Access Scenarios In A Multi-Indication Patient Flow Models

    Nov 1, 2016, 00:00

  • Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving While Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in France

    Nov 1, 2016, 00:00

  • The Economic Burden of Hypertension in Latin America

    Nov 1, 2016, 00:00

  • Mapping Quality of Life Scores from FACT-G, FAACT And FACIT-F Onto Preference-Based Utilities Using the 5-Level Version of EQ-5D Questionnaire

    Nov 1, 2016, 00:00

  • Healthcare Resource Consumption and Cost of Care in Patients with Autosomal Dominant Polycystic Disease (ADPKD) in Italy – Final Study Results

    Nov 1, 2016, 00:00

  • Estimation of The Direct Cost of COPD In Bulgaria

    Nov 1, 2016, 00:00

  • Evaluation of The Cost Saving Potential of Introducing An Etanercept Biosimilar (Benepali®) For The Treatment of All Licensed Adult Etanercept Indications In The UK

    Nov 1, 2016, 00:00

  • Replacing Input Probability Distributions with Mean Values can Bias Simulation Output- An Illustration Using the Core Diabetes Model

    Nov 1, 2016, 00:00

  • Comparing of Osteoplastic Biomaterials In The Operation of Regeneration of Alveolar Bone

    Nov 1, 2016, 00:00

  • Patterns of Care Among Pancreatic Cancer Patients- Findings from a u.s. Real-world claims-based analysis

    Nov 1, 2016, 00:00

  • Epidemiology and Costs of Psoriatic Arthritis in Germany – A Retrospective Claims Data Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma in Taiwan

    Nov 1, 2016, 00:00

  • Psychological Distress In Chinese Patients With Rheumatoid Arthritis And Psychometric Validation Of Chinese Hospital Anxiety And Depression Scale

    Nov 1, 2016, 00:00

  • The Apheresis- Database (APHDA)-Project- Patient Characteristics Treatment Patterns of Apheresis Patients in Germany

    Nov 1, 2016, 00:00

  • The EQ-5D-5L Instrument Demontrates Better Performance Compared With The EQ-5D-3L In Psoriatic Patients

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Bevacizumab Versus Cetuximab and Panitumumab in the Management of Colorectal Cancer from Patient Perspective in Egypt

    Nov 1, 2016, 00:00

  • Inhaled Iloprost Therapy and Pulmonary Arterial Hypertension- Experience in a Formulary Decision Study

    Nov 1, 2016, 00:00

  • Is the Lack of Inclusion on the National Drug Reimbursement List the end of the World for Access?

    Nov 1, 2016, 00:00

  • A Review of Health State Utility Values Used in UK Nice Appraisals in Advanced NSCLC

    Nov 1, 2016, 00:00

  • Info-Diabetic Approach from Cellular Phone Text Massaging can Minimize the Complexities in Diabetic Patient Care

    Nov 1, 2016, 00:00

  • Estimating the Economic Burden Associated with The Early Stages of Progression of Alzheimer’s Disease in Europe

    Nov 1, 2016, 00:00

  • Flexibly Modelling HBA1C Progression in Type 2 Diabetes to Estimate the Impact of Clinical Inertia on Costs and Quality Adjusted Life Years

    Nov 1, 2016, 00:00

  • The Relationship Between Antenatal Care And Health Facility Delivery

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Cyp2c19*2 Genotype Guided Selection of Clopidogrel or Ticagrelor in Hong Kong Chinese Patients with Acute Coronary Syndrome

    Nov 1, 2016, 00:00

  • Incidence And Prevalence of Multiple Myeloma From 2016 To 2020 According To The Treatment Line And Hematopoietic Stem Cell Transplantation Status

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Generic Versus Brand Form of Deferasiroix N The Management of B-Thalassemia Patients with Chronic Iron Overload- An Egyptian Health Care Provider Perspective

    Nov 1, 2016, 00:00

  • Unlocking Established Products Patient and Societal Value in Additional Indications

    Nov 1, 2016, 00:00

  • Measurement of Adherence To Anti-Hypertensive Drugs in Asia

    Nov 1, 2016, 00:00

  • Health Risk Of Drugs And Its Impact On Patient Adherence To Medical Treatment

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Neoadjuvant Chemotherapy with Pertuzumab, Trastuzumab and Docetaxel in Patients With HER2+ Breast Cancer in Spaincost-Utility Analysis of Neoadjuvant Chemotherapy with Pertuzumab, Trastuzumab and Docetaxel in Patien ...

    Nov 1, 2016, 00:00

  • The Effect of Physical Activity on the Mental and Emotional State of University Students

    Nov 1, 2016, 00:00

  • Regional Market Access Pathways for Diagnostics in Italy

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of First-Line Gefitinib, Erlotinib and Afatinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations

    Nov 1, 2016, 00:00

  • Hospital Admissions and Costs of Crohn's Disease in New Zealand and the Impact of Adalimumab

    Nov 1, 2016, 00:00

  • Modelling the Effectiveness of Ibrutinib Versus Rituximab-Based Chemotherapy Regimens in Relapsed/Refractory Mantle Cell Lymphoma

    Nov 1, 2016, 00:00

  • Uptake of Hepatitis B HIV Co-Infection Screening And Management In A Resource Limited Setting

    Nov 1, 2016, 00:00

  • Application of Multi-Criteria Decision Analysis (Mcda) Scoring as an Hta Methodology for off-Patent Pharmaceuticals (Opp) in Emerging Markets

    Nov 1, 2016, 00:00

  • Cost Minimisation Analysis- When And Where? A Review Of Hta Guidance On Cost Minimisation Analysis

    Nov 1, 2016, 00:00

  • Quality of Life of Patients Treated for Multiple Myeloma (MM) in France in a Real-World Setting

    Nov 1, 2016, 00:00

  • Survival And Death Risk of Patients With Prostate Cancer Treated In The Brazilian Public Health System

    Nov 1, 2016, 00:00

  • Is External Reference Pricing A Threat to International Equal Affordability?

    Nov 1, 2016, 00:00

  • Brain Metastasis Prediction in Breast Cancer Women- Usefulness of Mathematical Modeling of Montecarlo

    Nov 1, 2016, 00:00

  • The Burden of Comorbid Allergic Rhinitis and Asthma

    Nov 1, 2016, 00:00

  • The Relationship Between Medical Innovation And Health Expenditures

    Nov 1, 2016, 00:00

  • Innovative Contracting- Evolving use of Web-Based Managed Entry Agreements in Italy

    Nov 1, 2016, 00:00

  • Glatiramer Acetate (Ga) Is Cost-Effective Compared To Interferons And Best Supportive Care (Bsc) For Relapsing Remitting Multiple Sclerosis (Rrms) In The Uk

    Nov 1, 2016, 00:00

  • Real-World Evidence of Ruxolitinib In The Treatment of Myelofibrosis- Experince of A Portuguese Hospital Center

    Nov 1, 2016, 00:00

  • Review of Health Economic Models for Antibiotics

    Nov 1, 2016, 00:00

  • Estimation of National Economic Burden of Hypoglycaemia Among Type 2 Diabetes Mellitus Patients in Malaysia

    Nov 1, 2016, 00:00

  • Characteristics of Patients with Type 2 Diabetes Mellitus Initiated on Basal Insulin Regimens- Retrospective Analysis of Electronic Health Record Data

    Nov 1, 2016, 00:00

  • Skeletal-Related Events (SRES) and Renal Function in Patients with Symptomatic Multiple Myeloma (MM)- Results from Belgium, France, Germany, Italy, Spain, Switzerland and The United Kingdom

    Nov 1, 2016, 00:00

  • Comparison of Trend, Outcome, and Cost of open, Laparoscopic, and Robotic Surgical Treatment for Colorectal Cancer- A Propensity Score Matched Analysis of A National Database

    Nov 1, 2016, 00:00

  • Tax Losses and Gains Attributed to Smoking Cessation in Korea

    Nov 1, 2016, 00:00

  • The Challenge of Critical Mass To Be Overcome By International HTA Networks

    Nov 1, 2016, 00:00

  • Risk Share Agreements (RSA), Product Listing Agreements (PLA) or Patient Access Schemes (PAS) - All the Same or Different?

    Nov 1, 2016, 00:00

  • Using A Discrete Choice Experiment To Value Informal Care Provided To Children with Intellectual Disabilities

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Abiraterone Used for Metastatic Castrate-Resistant Prostate Cancer Before Chemotherapy

    Nov 1, 2016, 00:00

  • Biosimilar Infliximab In The 37 Public Hospitals Of Paris- Meeting The Challenge Of Substitution

    Nov 1, 2016, 00:00

  • Methodological Review of Survival Models- Application to A Persistence Analysis Based on Long Acting Parenteral Antipsychotic in Retail Pharmacies in France

    Nov 1, 2016, 00:00

  • A Review of Treatment on Alzheimer's Disease in China

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab for Treating Previously Untreated Metastatic Melanoma Patients in France

    Nov 1, 2016, 00:00

  • The Structure and Vascularization of Choroid Plexus of Brain in Children Aged From 0–3 Years Old

    Nov 1, 2016, 00:00

  • The Public Acceptance And Willingness-To-Pay (Wtp) Of Dengue Vaccine In Penang, Malaysia- Assessment with A Contingent Valuation Study

    Nov 1, 2016, 00:00

  • Different Values In Cost-Effectiveness Research- Institute for Clinical and Economic Review (ICER) VS. The National Institute for Care Excellence (NICE)

    Nov 1, 2016, 00:00

  • Impact of Adherence on Subcutaneous Interferon Beta-1a Effectiveness Administered by Rebismart® in Patients with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Newer Antiepileptic Drugs (Aeds) For Management of Partial Epilepsy In Children In Malaysia

    Nov 1, 2016, 00:00

  • Generating Health Utility Values From US SF-36 Scores For French Assessment- Comparison of 3 Mapping Methods

    Nov 1, 2016, 00:00

  • Implemantation of Processes to Estabilishing a HTA Unit in Czech Hospital Enviroment

    Nov 1, 2016, 00:00

  • The Economic Burden of Four Heart Conditions in Mexico

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Pirfenidone For The Treatment of Mild To Moderate Idiopathic Pulmonary Fibrosis (IPF) Compared To Best Supportive Care And Nintedanib From The Italian NHS Perspective

    Nov 1, 2016, 00:00

  • Antibiotic Treatment of Uncomplicated Urinary Tract Infection In Women- A Comparative Cost-Effectiveness Study

    Nov 1, 2016, 00:00

  • Analysis of Patients' Satisfaction on the Implementation of Essential Drug System in China

    Nov 1, 2016, 00:00

  • Budget Impact of Etanercept Biosimilars In The Treatment of Rheumatoid Arthrisis- An Analysis Based on French National Claims Database

    Nov 1, 2016, 00:00

  • Direct Healthcare Costs and Clinical Outcomes of Open Abdominal Aortic Aneurysm Repair in Spain. Recapta Study

    Nov 1, 2016, 00:00

  • Australian Influenza National Surveillance Data (2009 to 2014) – Variations by Sex, Age Group, and Influenza Type

    Nov 1, 2016, 00:00

  • Real World Utilization of Biological Agents in Rheumatoid Arthritis Patients- A French National Claims Database Analysis Over The Period 2010–2014

    Nov 1, 2016, 00:00

  • Prescribing Pattern of Anti Hypertensive Agents in A Tertiary Care Hospital Outpatient Department

    Nov 1, 2016, 00:00

  • Association Between Eq-5d And Changes in Asthma Symptoms, Severity, and Qol In Patients With Severe Eosinophilic Asthma

    Nov 1, 2016, 00:00

  • Safety and Efficacy of High-Potency Statin and Ultra-Low LDL in Chinese Patients with Established Cardiovascular Disease- Practice Impact of the New Cholesterol Guidelines

    Nov 1, 2016, 00:00

  • Predictors of 1 Year Mortality in Patients with Contralateral HIP Fracture After Femoral Neck Fracture

    Nov 1, 2016, 00:00

  • Jointly Modeling Survival and EQ-5D Data to Estimate Health Utilities for Her2+ Metastatic Gastric Cancer

    Nov 1, 2016, 00:00

  • Evaluating the Relative Effectiveness of Two Malnutrition Risk Assessment Tools in Surgical Population at a Tertiary Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Absence of Price-Prevalence Correlation in Orphan Drugs in Italy

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Cosyrel for The Treatment of Hypertension in Italy

    Nov 1, 2016, 00:00

  • Characteristics and Outcomes of Patients with Hospital-Acquired Pneumonia (Hap)

    Nov 1, 2016, 00:00

  • Effectiveness of A Referral Program For Early Arthritis Diagnosis At Primary Care Centers In Portugal - Final Results From The Siara Study

    Nov 1, 2016, 00:00

  • Reflecting Uncertainty in Early HTA When Evidence on Parameter Distributions is Lacking- A Comparison of Methods

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Perception of the General Public Regarding Polio and its Vaccination in Khyber Pakhtunkhwa, Pakistan. a Qualitative Study

    Nov 1, 2016, 00:00

  • Economic Burden of Colorectal Resections- Incremental Effects in Cancer Patients

    Nov 1, 2016, 00:00

  • Pro Instruments Used In Studies Published Since 2005- Which Populations And Diseases Have Had The Most Tools Developed?

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Practice Towards Hepatitis B Among Medical College Students of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Solifenacin for The Treatment of Overactive Bladder From A Us Private Payer and Medicare Advantage Perspective

    Nov 1, 2016, 00:00

  • Budget Impact of Continuous Subcutaneous Insulin Infusion Compared with Multiple Daily Insulin Injections for The Treatment of Type 1 Diabetes in Spain

    Nov 1, 2016, 00:00

  • The Impress (International Multiple Sclerosis) Study; Results On The Socio-Economic Burden, Health Related Quality Of Life And Experience Of Multiple Sclerosis Patients In France

    Nov 1, 2016, 00:00

  • Antibiotic Utilisation and Expenditure in Ireland

    Nov 1, 2016, 00:00

  • Modeling the Cost-Effectiveness of Statin Therapy in Rheumatoid Arthritis A Markov-Cycle Evaluation From the National Data Bank for Rheumatic Diseases

    Nov 1, 2016, 00:00

  • Analysis of Cardiovascular Disease Burden on The Insured Population of Units Directly Under Fujian Province

    Nov 1, 2016, 00:00

  • Quantifying Informal Versus Formal Care, and Financial Caregiver Burden, for Stroke Patients in Asia- A Structured Literature Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of An Automated Medication System Implemented In A Danish Hospital Setting

    Nov 1, 2016, 00:00

  • Trends in Japanese Clinical Trial Registration from 2005 to 2014

    Nov 1, 2016, 00:00

  • Health Technology Assessment on Continuous And Intermittent Renal Replacement Therapies For Acute Kidney Injury In Adult Patients

    Nov 1, 2016, 00:00

  • Economic Assessment of Dydrogesterone Compared with Progesterone for the Treatment of Threatened Andhabitual Miscarriage in China

    Nov 1, 2016, 00:00

  • Resource use in Chronic Heart Failure in the UK- A Systematic Review

    Nov 1, 2016, 00:00

  • Paucity of Clinical Data in Oncology HTA Submissions- Key Learnings from Recent Case Studies

    Nov 1, 2016, 00:00

  • Cross-Validation of A 7-Item Clinical Decision Rule for Detecting Panic-Related Anxiety in Emergency Medicine Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Radial Access Versus Femoral for Diagnostic Cardiac Catheterization and Coronary Intervention in Colombia

    Nov 1, 2016, 00:00

  • Cost of Antihyperglycemic Therapy In Type 2 Diabetes Patients Depending on HBA1C And Bmi Values

    Nov 1, 2016, 00:00

  • Implementation of One Stop Diagnosis In Patients with Thyroid Nodules- Impact on Cost And Surgery

    Nov 1, 2016, 00:00

  • Eliciting Stated Preferences Regarding Life Extensions Near the End of Life- A Pilot Study for a Refinement of the Qaly

    Nov 1, 2016, 00:00

  • Improving the System of Healthcare Provision for Patients with Diffuse Toxic Goiter in Ukraine

    Nov 1, 2016, 00:00

  • How Well is Warfarin Controlled In Real World Clinical Practice in Hong Kong?

    Nov 1, 2016, 00:00

  • Content Validation of the Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT®) Questionnaire

    Nov 1, 2016, 00:00

  • Rosuvastatin- Switching Treatment and Clinical Implications in Primary Care

    Nov 1, 2016, 00:00

  • The Economic Evaluation of Bone-Anchored Hearing AIDS (BAHAS)- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Diareg – Results from an Diabetes Register with Focus on Patient Reported Outcomes

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of a Combination of Renin-Angiotensin System Inhibitors (Ras)/Calcium Channel Blockers (Ccb) or Ras Monotherapy to Retard Progression of Kidney Disease in Malaysia

    Nov 1, 2016, 00:00

  • Assessing Quality Of Life Of Self-Reported Rheumatic Patients

    Nov 1, 2016, 00:00

  • Differences In Pricing Policies For Generic And Biosimilar Medicines

    Nov 1, 2016, 00:00

  • What are the Most Important Decision-Making Criteria For Innovative Health Technology Integration? A National Survey from French Hospitals Decision-Makers

    Nov 1, 2016, 00:00

  • Copyright/Subscription

    Nov 1, 2016, 00:00

  • The Economic Burden of Heart Failure in Greece From A Social Security System Perspective

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Panitumumab Vs Cetuximab as Monotherapy for Chemo-Refractory Patients with WT KRAS MCRC in Mexico

    Nov 1, 2016, 00:00

  • Therapeutic Indication of Lyophilized Hydrocortisone to the Treatment of Trichinosis with Neurological and / or Myocardial Involvement

    Nov 1, 2016, 00:00

  • Economic Burden of Schizophrenia in China- A Literature Review

    Nov 1, 2016, 00:00

  • Self-Reported Client Satisfaction In The Primary Care Development Model Programme

    Nov 1, 2016, 00:00

  • Extracting Dosage Per Day From Free-Text Medication Prescriptions

    Nov 1, 2016, 00:00

  • Was the Consistency of Data Improved after Separating the Better than Health (BTD) and Worse than Death (WTD) Tasks and Implementing a Feedback Module (FB) in Composite Time Trade off (CTTO) Exercise?

    Nov 1, 2016, 00:00

  • Generating Real World Eviden Guidance On The Design And Conduct Of Retrospective Chart Review Studies

    Nov 1, 2016, 00:00

  • Public Knowledge and Attitudes Towards Zika Virus and its Prevention in Malaysia

    Nov 1, 2016, 00:00

  • The Incidence of Hypoglycemia in Type II Diabetes Mellitus (T2DM) Patients Treated with Insulin Therapy in Combination with DPP-4 in Greece. A Sub-Analysis of Hypo 2 Study

    Nov 1, 2016, 00:00

  • Network Meta-Analysis To Assess The Relative Efficacy of Empagliflozin Monotherapy Over 24, 52, And 76 Weeks In Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Serelaxin in Treatment of Patients with Acute Decompensated Heart Failure

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Fingolimod Vs Brace Cycling Followed By A Switch To Fingolimod In Patients Failing Prior Treatment

    Nov 1, 2016, 00:00

  • Direct Medical Costs Associaed with Diabetic Complicaitons in Patients with Type 2 Diabetes in Us and South Korea

    Nov 1, 2016, 00:00

  • Generic Drug Utilization Among The Elderly With Multiple Chronic Conditions In The United States

    Nov 1, 2016, 00:00

  • The Cost Of Relapse Remitting Multiple Sclerosis Disease - Patient Reported Study In Egypt

    Nov 1, 2016, 00:00

  • Lenalidomide for Treating Multiple Myeloma After 1 Prior Treatment; An Application of Multi-State Markov Modelling for the Extrapolation of Patient Level Survival Data

    Nov 1, 2016, 00:00

  • Day Surgery Vs Regular Admission- Activity-Based Cost Analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) Procedures From Hospital Perspective

    Nov 1, 2016, 00:00

  • Treatment Resistant Depression Development From Major Depressive Disorder- A Claims Database Analysis In Japan

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada

    Nov 1, 2016, 00:00

  • Herpes Zoster And Postherpetic Neuralgia- Quality Of Life And Healthcare Utilization, A German Study

    Nov 1, 2016, 00:00

  • Utility By Treatment Line In Multiple Myeloma; Analysis of Over 9000 EQ-5Q-3L Questionnaires from the Emmos Registry

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Interventions on Non-Alcoholic Fatty Liver Disease (NAFLD)- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • HCV- Estimation of the Number of Diagnosed Patients Eligible to New Anti-HCV Therapies in Italy

    Nov 1, 2016, 00:00

  • Good Enough For Policy Work? Study-Design Challenges In Implementing Stated-Preference Methods For Complex Health-Care Technologies

    Nov 1, 2016, 00:00

  • The Case For Bayesian Methods In Benefit-Risk Assessment- Overview And Future Directions

    Nov 1, 2016, 00:00

  • The Impact of Treatment Adherence on Clinical and Economic Outcomes in Multiple Sclerosis- Real-World Evidence from Alberta, Canada

    Nov 1, 2016, 00:00

  • Alcoholism In Italy- An Introductive Analysis of Consumption And Hospitalisation Trends

    Nov 1, 2016, 00:00

  • Increasing Trend Of Health Related Quality Of Life Awareness For Diabetic Care Among Indian Scientists

    Nov 1, 2016, 00:00

  • Estimation of Willingness to Pay for a Quality-Adjusted Life Year on a Cure

    Nov 1, 2016, 00:00

  • Assessment of CTX-1 Bone Biomarker As An Indicator of Antiresorptive Therapy Efficacy And of Persistence In A Fracture Liaison Service

    Nov 1, 2016, 00:00

  • Linear, Flat And Mixed Pricing Structures As Negotiation Quantities Of New Medicinal Products In Context Of Amnog In Germany- A Comparison At Market Launch And Post Price Negotiations

    Nov 1, 2016, 00:00

  • A Modeled Health Economic Analysis of the Accucath® Intravenous Catheter System with Retractable Coiled Tip Guidewire Compared with Conventional Peripheral Intravenous Catheters

    Nov 1, 2016, 00:00

  • Trends In Outpatient Use Of Antibiotics In Croatia

    Nov 1, 2016, 00:00

  • A UK Observational Cohort Study of Insulin Treatment Patterns and Characterisation of Insulin Users in Type 1 And Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Hepatitis C Treatment with First-Generation Protease Inhibitors in A Real-World Cohort- Risk-Benefit Profile and Costs of the Therapy

    Nov 1, 2016, 00:00

  • Efficacy and Safety of Azathioprine for Multiple Sclerosis- A Rapid Review

    Nov 1, 2016, 00:00

  • Evaluation of Quality of Pharmacoeconomic Studies in Asia Pacific and Identification of Influencing Variables

    Nov 1, 2016, 00:00

  • Consumer Perception of Communication with Healthcare Professionals (HCPS) and Information Clarity Concerning Newly Prescribed Medication

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sq® Hdm Slit-Tablet For House Dust Mite Respiratory Allergic Disease In Czech Republic

    Nov 1, 2016, 00:00

  • How can healthcare pathways explain polypharmacy in france? A longitudinal analysis between 2011 and 2014

    Nov 1, 2016, 00:00

  • Rare and Intractable Disease Policy Reform in Japan- A Before and After Analysis

    Nov 1, 2016, 00:00

  • An Economic Analysis on Optimal Management of Fragility Hip Fractures In Geriatric Patients Adopting The Geriatric Fracture Program

    Nov 1, 2016, 00:00

  • Incidence and Risk Factors of Glucocorticoid-Induced Diabetes Mellitus in Lymphoma Patients Treated with Glucocorticoid-Containing Chemotherapy

    Nov 1, 2016, 00:00

  • Advanced Soft Tissue Sarcoma- Systemic Treatment Patterns and Survival in Germany

    Nov 1, 2016, 00:00

  • Annual Cost Аnalysis for Medicinal Products for Rare Diseases in Bulgaria

    Nov 1, 2016, 00:00

  • The assessment of advanced medicinal products (atmp) in germany- is the practice to define atmp drugs as procedures in compliance with european legislation?

    Nov 1, 2016, 00:00

  • Determination Of The Vaccine-Preventable Diseases Burden In Turkey In Terms Of Various Vaccination Policies

    Nov 1, 2016, 00:00

  • Azacitidine For The Treatment of Adult Patients (Age 65 or Older) with Acute Myeloid Leukemia And >30% Bone Marrow Blasts In Spain- Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Optimal Design of Pre-Authorization Trials for Effectiveness Evaluation in Severe Asthma

    Nov 1, 2016, 00:00

  • Incremental Burden of Cancer in Patients Undergoing Hepatic Resections- Results From A National Hospital Billing Data

    Nov 1, 2016, 00:00

  • Epidemiological Characteristics Of Hospitalizations Due To Adverse Drug Reactions (Adrs) Relaed To Oral Anticoagulants In Spain- 2010-2013

    Nov 1, 2016, 00:00

  • Managing Healthcare Resources- Estimated Budget Impact On The National Health Service (England) Of Introduction Of Antimicrobial Sutures

    Nov 1, 2016, 00:00

  • Swedish Perspective on Health Technology Assessments with Incrementally Lower Costs and Effects

    Nov 1, 2016, 00:00

  • Development Of Predictive Models For The Analysis Of The List Of Vital Essential And Necessary Drugs Compilation

    Nov 1, 2016, 00:00

  • Pro Instruments for Musculoskeletal Disorders used in Studies Published Since 2005- Which Diseases have had the most Tools Developed?

    Nov 1, 2016, 00:00

  • Evaluation of The Cost Saving Potential of Introducing Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Four Regions In Germany

    Nov 1, 2016, 00:00

  • Impact of Hypoglycaemic Events on Healthcare Resource Use in Type 2 Diabetes Patients

    Nov 1, 2016, 00:00

  • The Introduction of Etanercept Biosimilar In The Practice of A Tertiary Rheumatologic Centre In Italy- A Budget Impact Model

    Nov 1, 2016, 00:00

  • Closed-System Transfer Device for Preparation of Antineoplastic Drugs in a Malaysian Public Hospital- Is it Truly Cost Saving?

    Nov 1, 2016, 00:00

  • Systematic Review Toolbox

    Nov 1, 2016, 00:00

  • The Impact Of Cost Sharing Arrangements In The Use Of Health Care Services During The Economic Crisis In Greece And The Attitudes Of Citizens

    Nov 1, 2016, 00:00

  • Early Payer Scientific Advice Procedures In The Eu- Which One Is Most Suited For Pharmaceutical Compaines?

    Nov 1, 2016, 00:00

  • Satisfaction Level of Patients, Physicians, and Private Primary Healthcare Center Managers with Chronic Disease Management Program in Indonesia

    Nov 1, 2016, 00:00

  • Causes of Death Statistics Underestimate the Burden of Head and Neck (HN) Cancers- A Nationwide Study From France in 2008-2012 (Epicorl Study)

    Nov 1, 2016, 00:00

  • Quality of Life of Patients with Alzheimer's Disease - A Comparison with General Population

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Brand-Name and Generic Warfarin on Stroke and Bleeding Events in Atrial Fibrillation Patients- A 6-Year Population-Based Retrospective Cohort Study in Taiwan

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment Of Pegaspargase Versus Asparaginase in Acute Lymphocytic Leukemia

    Nov 1, 2016, 00:00

  • Real-World Hospitalisation and Mortality of Incident and Prevalent Patients with Heart Failure Due to Left Ventricular Systolic Dysfunction in England

    Nov 1, 2016, 00:00

  • Translation of the DN4 (Douleur Neuropathique EN 4 Questions) INTO 85 Languages- Challenges and Importance of the Conceptual Defintion of the Original Version

    Nov 1, 2016, 00:00

  • Prevalence and Patient Characteristics of Multiple Sclerosis (Ms) in Japan

    Nov 1, 2016, 00:00

  • Trends in The Utilization, Spending, and Prices For Smoking Cessation and Nicotine Replacement Products In US Medicaid Programs- 1991–2015

    Nov 1, 2016, 00:00

  • Analysing the Prescribing Landscape for Oral Anticoagulants

    Nov 1, 2016, 00:00

  • Preference For Cervical Cancer Screening In Rural China- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Stock Reduction of Erythropoietin for Patients on Hemodialysis at Somdech Phra Debaratana Medical Center

    Nov 1, 2016, 00:00

  • A Proposed Model for the Study of the Longitudinal Behavior of Prevalence Rates

    Nov 1, 2016, 00:00

  • Childhood Stunting, Wasting and Obesity in Indonesia- Evidence from the Indonesian Family Life Survey

    Nov 1, 2016, 00:00

  • The Economic Burden of Four Heart Conditions in Brazil

    Nov 1, 2016, 00:00

  • Economic Evaluation of Drug Wastage Impact on Healthcare Expenditures in French Hospitals

    Nov 1, 2016, 00:00

  • A Systematic Review of Utility Derivation Methods- Time Trade off in Comparison to EQ-5D

    Nov 1, 2016, 00:00

  • Combining A Real-World Observational Study And A Network Meta-Analysis of Randomised Controlled Trials To Determine Relative Treatment Effects In Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Real-World Outcomes and Resource Utilisation Following Onabotulinumtoxina Treatment For Severe Lower Limb Focal Spasticity in Adults – Database Analysis at An Australian Hypertonicity Clinic

    Nov 1, 2016, 00:00

  • Cost of Illness of Ankylosing Spondylitis In Egypt From Payer Prospective

    Nov 1, 2016, 00:00

  • Impaired Quality Of Life After Chikungunya Virus Infection- A 12-Months Follow-Up Study Of Its Chronic Inflammatory Rheumatism In La Virginia, Risaralda, Colombia

    Nov 1, 2016, 00:00

  • Relationship between Insulin Adherence and Health Care Resource Utilization among Type 2 Diabetes Patients in China

    Nov 1, 2016, 00:00

  • Is Big Data in Healthcare about Big Hope or Big Hype? Early Health Technology Assessment of Big Data Analytics in Healthcare

    Nov 1, 2016, 00:00

  • Assessing The Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Inoperable Patients with Severe Aortic Stenosis in UK

    Nov 1, 2016, 00:00

  • Proton Pump Inhibitors and Major Adverse Cardiovascular Outcomes- A Systematic Review

    Nov 1, 2016, 00:00

  • Treatment Patterns of Relapsed and Refractory Multiple Myeloma in Europe (EU-28)

    Nov 1, 2016, 00:00

  • Priority Setting of Medical Device for Patient Safety in Korean Hospitals

    Nov 1, 2016, 00:00

  • Economic Burden of Ankylosing Spondylitis In Europe. A Systematic Review of The Literature

    Nov 1, 2016, 00:00

  • Economic Consequences Of The Choices In Injectable Anticoagulants In France

    Nov 1, 2016, 00:00

  • Time To Formal ‎Reimbursability ‎For Innovative ‎Drugs In Italy ‎

    Nov 1, 2016, 00:00

  • Mathematical Model to Synthesize Natural History of Tick Borne Encephalitis and Lyme Borreliosis for the Purpose of Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • A Restrospective Non-Interventional Study Among Patients with Relapsing Multiple Sclerosis Switching to Fingolimod or to Other Disease Modifying Therapies

    Nov 1, 2016, 00:00

  • Economic Burden Of Diseases In Fran Analysing The Trends From 2012 To 2014, Using The French Health Insurance Database (Sniiram)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Highly Innovative Treatments For Hepatitis C- The Case Of Ledipasvir/Sofosbuvir In A Greek Healthcare Setting

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab vs. Docetaxel as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

    Nov 1, 2016, 00:00
  • «
  • 81
  • 82 (current)
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »